Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
S
Sungha Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
853
Papers
18.1K
Citations
61
h-index
352
i10-index
Sungha Park is an academic researcher from Gachon University. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Cardiovascular Health and Disease Prevention & Heart Rate Variability and Autonomic Control. The author has an h-index of 61, co-authored 726 publications.
ORCID: 0000-0001-5362-478XPapers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults
2020 · Circulation · 168 citations
https://doi.org/10.1161/circulationaha.119.044838
Prediction of systemic biomarkers from retinal photographs: development and validation of deep-learning algorithms
2020 · The Lancet Digital Health · 161 citations
https://doi.org/10.1016/s2589-7500(20)30216-8
Application of genetically engineered Salmonella typhimurium for interferon-gamma–induced therapy against melanoma
2016 · European Journal of Cancer · 105 citations
https://doi.org/10.1016/j.ejca.2016.10.010
Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network
2018 · Journal of Human Hypertension · 95 citations
https://doi.org/10.1038/s41371-017-0025-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat